KWON YOUNG 4

4 · ADMA BIOLOGICS, INC. · Filed Feb 11, 2026

AI-generated summary of this filing

Updated Feb 12, 2026

ADMA BIOLOGICS (ADMA) Director Kwon Young Receives RSU Award

What Happened

Director Kwon Young was granted equity awards by ADMA BIOLOGICS on February 9, 2026. The filing shows two acquisitions: 10,690 restricted stock units (RSUs) and 17,730 derivative awards (options/other derivative awards), all reported at $0. No cash was paid — these are compensation awards, not open-market purchases.

Key Details

Transaction date: February 9, 2026; Form 4 filed February 11, 2026 (appears timely).
Grants: 10,690 RSUs (reported as an award) and 17,730 derivative awards (reported as an award/derivative).
Reported price: $0.00 (typical for compensation grants; market value depends on ADMA’s share price).
Shares/units reported after the transaction (per footnote): 246,885 shares of common stock owned, 10,690 RSUs newly granted (vest Feb 9, 2027 per F2), and 5,445 RSUs from a 2025 grant that vest Feb 19, 2026 — totaling 263,020 shares/RSUs counted in the filing; plus 17,730 derivative awards that vest under a separate schedule.
Vesting notes: The 10,690 RSUs vest in two equal installments (6- and 12-month anniversaries) and become fully vested after one year (F1/F2). The 17,730 derivative awards vest monthly over 12 months, fully vesting after one year (F3).
No indication of a 10b5-1 plan, sale, tax withholding, or late filing in this Form 4.

Context

These are compensation awards, not open-market purchases or sales. Grants at $0 are standard for RSU/option awards; their realized value depends on ADMA’s future share price and the recipient’s continued service through vesting dates.
For retail investors, awards to directors signal management/board compensation alignment with shareholders but are routine and do not by themselves indicate insider buying or selling sentiment.

Form 4

Period: 2026-02-09

Director

Transactions

Award
Common Stock
[F1][F2]
2026-02-09+10,690→ 263,020 total
Award
Stock Option (Right to Buy)
[F3]
2026-02-09+17,730→ 17,730 total
Exercise: $16.37Exp: 2036-02-09→ Common Stock (17,730 underlying)

Footnotes (3)

[F1]These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the applicable vesting date.
[F2]Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; (ii) 5,445 RSUs out of 10,889 RSUs granted on February 19, 2025, which will vest fully on February 19, 2026, subject to the Reporting Person's continued service as of such vesting date; and (iii) 246,885 shares of common stock owned by the Reporting Person.
[F3]These options vest in twelve equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.

Signature

/s/ Young Kwon, by Michael A. Goldstein as Attorney-in-fact|2026-02-11

1 file